AI Verdict
MGNO has stronger fundamentals based on our AI analysis.
MGNO vs MGX Fundamental Comparison
| Metric | MGNO | MGX |
|---|---|---|
| Revenue | $6,000.0 | $25.2M |
| Net Income | $-170,000.0 | $-87.9M |
| Net Margin | -2,833.3% | -348.5% |
| ROE | -0.9% | -55.4% |
| ROA | -0.5% | -39.7% |
| Current Ratio | N/A | 7.22x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | N/A | $-2.36 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MGNO vs MGX: Frequently Asked Questions
Is MGNO or MGX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MGNO has stronger fundamentals. MGNO is rated STRONG SELL (95% confidence) while MGX is rated STRONG SELL (92% confidence). This is not investment advice.
How does MGNO compare to MGX fundamentally?
Magnolia Bancorp, Inc. has ROE of -0.9% vs Metagenomi Therapeutics, Inc.'s -55.4%. Net margins are -2,833.3% vs -348.5% respectively.
Which stock pays higher dividends, MGNO or MGX?
MGNO has a dividend yield of N/A or no dividend while MGX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MGNO or MGX for long term?
For long-term investing, consider that MGNO has STRONG SELL rating with 95% confidence, while MGX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MGNO vs MGX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MGNO vs MGX, the AI consensus favors MGNO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.